NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Clinical Trials 248

Clinical Trials Chronic Pain Cannabinoids Patients 248

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. For more information, please visit www.trutrace.co.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

OCTOBER 26, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Chapman has operated Chapman Pharmaceutical Consulting, Inc., About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JUNE 23, 2021

RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 19, 2021

The industrial hemp market is being driven by the rising application of the fibre in various industries, including food and beverage, personal care, pharmaceutical and textiles, among others. 12 Trade Data Analysis (HS Code: 5302). 15 Industry Events and Developments. Key Topics Covered: 1 Preface. 3 Report Description.

Hemp 98

Hemp Research and Development Pharmaceutical Data 98

Cannabis Law Report

OCTOBER 3, 2019

The event will serve as a platform for Icelandic consumers and entrepreneurs to learn about the many potential business opportunities and wellness benefits that hemp and hemp-derived cannabidiol (CBD) could bring to their country. . According to New Frontier Data , the global hemp market reached $3.74 billion by 2020.

Events 40

Events Hemp Research and Development Supply Chain 40

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma will seek to identify scientific gaps in the cannabis industry and ultimately work to translate that to pharmaceutical cannabis products backed by data. The immediate next steps are to submit data for ethics committee review and approval whereupon acceptance, further details will be provided. “A

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

Veriheal

JULY 12, 2021

According to the American Psychiatric Association , PTSD is a “psychiatric disorder that may occur in people who have experienced or witnessed a traumatic event such as natural disaster, as a serious accident, a terrorist act, war/combat or rape or who have been threatened with death, sexual violence or serious injury”.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

The Joint Blog

DECEMBER 20, 2020

Separate survey data of US women previously reported that more than 20 percent of subjects with pelvic pain consume cannabis products, with 96 percent of consumers reporting symptom improvement.” Data were collected on demographics, modes of cannabis administration, symptoms treated, changes in pharmaceutical usage, and adverse events.

Sleep 49

Sleep Data Pharmaceutical Marijuana 49

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

Cannabis Law Report

FEBRUARY 3, 2022

The Smart Event, comprising in-person and online platforms, to convene thousands of engineers, business leaders, disruptive companies, and innovative thinkers to design powerful solutions to today’s most pressing challenges. ANAHEIM, Calif.–(BUSINESS The online platform will open on March 14 and is accessible to all registered visitors.

Packaging 52

Packaging Events Education Supply Chain 52

Cannabis Law Report

AUGUST 14, 2021

A founding member of the Industrial Hemp branch of China National Narcotic Drugs Association, CBDer is also an R&D partner with KPC Pharmaceuticals (SSE: 600422) in breeding high CBD potency hemp cultivars. The MOU mainly encompasses: Working with CBDer to further develop China’s industrial hemp market. CSE: MARY).

Hemp 105

Hemp Supply Chain Cannabinoids Extraction 105

Cannabis Law Report

NOVEMBER 4, 2021

Hybrid Event Pairs In-Person Trade Show with Virtual Offerings through SupplySide Network 365 to Provide Opportunities for Innovation Professionals to Do Business. SupplySide Network 365 brought exciting advances and created new ways for industry members at the event and remote to connect and engage with show content.

Food 40

Food Events Supply Chain Business 40

Cannabis Law Report

DECEMBER 6, 2021

The Company recently presented initial data describing a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using the combination of cotton genomics and isotopic analysis (IA) at an American Apparel and Footwear Association event. Investor Contact: Sanjay M.

Supply Chain 52

Supply Chain Therapy Research and Development Data 52

Cannabis Law Report

SEPTEMBER 8, 2021

All the data points associated to tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform can be used across industries such as textiles, cannabis, military, leather, fertilizer, pharmaceuticals, personal care. About Flora Growth Corp. For more information, please visit [link].

Supply Chain 96

Supply Chain Therapy Pharmaceutical Food 96

Cannabis Law Report

FEBRUARY 2, 2022

We are excited for our Flora Pharma researchers to build upon this progress and generate new data for how cannabis could help consumers around the world, leveraging this natural, botanical alternative,” Merchan said. About Flora Growth Corp. Forward-looking statements are only predictions. Investor Relations: Evan Veryard.

Cannabinoids 52

Cannabinoids Clinical Trials Events Cultivation 52

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. To learn more about the effectiveness of cannabis as a treatment for PD, a survey was sent to more than 7,600 people who had interacted with the Parkinson’s Foundation through events or the group’s helpline.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JUNE 7, 2021

1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The study showed neutralizing antibody titers against B.1.1.7 Dr. James A.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

DECEMBER 15, 2021

The signing of the MoU follows the joint presentation of initial data by the companies at an American Apparel and Footwear Association event that describes a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using cotton genomics with affirmation by IA.

Supply Chain 52

Supply Chain Therapy Research and Development Events 52

Cannabis Law Report

NOVEMBER 23, 2021

The Company has state-of-the-art cultivation facilities in Portugal and Germany that supply pharmaceutical-grade medical cannabis across international markets, as well as sales and distribution arrangements to supply cannabis through major pharmaceutical distribution channels. .: In the E.U., when the time comes.

Research and Development 52

Research and Development Cultivation Pharmaceutical Packaging 52

Cannabis Law Report

SEPTEMBER 27, 2021

All the data points associated with tagging and testing are tracked by uploading to a secure cloud database. The CertainT platform can be used across industries, including textiles, cannabis, military, leather, fertilizer, pharmaceuticals, and personal care. About Applied DNA Sciences. For Applied DNA: Investor contact: Sanjay M.

Supply Chain 52

Supply Chain Therapy Research and Development Pharmaceutical 52

Cannabis Law Report

JANUARY 18, 2022

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Investor Relations Contact: Sanjay M.

Research and Development 52

Research and Development Therapy Supply Chain Collective 52

Cannabis Law Report

AUGUST 23, 2021

He added that significant data is still needed to inform policy regarding use of consumer cannabis products. Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

SEPTEMBER 15, 2021

Total retail sales in Missouri are expected to grow to USD$650 million by 2025 per New Frontier Data. The state of Missouri surpassed 100,000 patients in May 2021 (seven months after the first sale) and robust patient adoption trends have continued since. market in Missouri.

Events 52

Events Dispensary Extraction Cannabis 52

Cannabis Law Report

SEPTEMBER 2, 2021

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. For Applied DNA: Investor contact: Sanjay M.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

JUNE 1, 2021

Prior to UroGen, Mr. Barbera held various leadership roles at Dendreon Pharmaceuticals, Allergan, and Medimmune, among others. The Company anticipates that subsequent events and developments will cause the Company’s views to change.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

OCTOBER 12, 2021

Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. For Applied DNA: Investor Contact: Sanjay M.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 2, 2022

post-pandemic owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health.” ( See [link] ). Investor information is available at www.olb.com/investors-data and www.Dmint.com. Hemp-derived CBD is expected to grow at a CAGR of 23.4% Safe Harbor Statement.

eCommerce 52

eCommerce CBD Environment Pharmaceutical 52